+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infectious Disease Drug"

Glycoprotein 41 (gp41) - Pipeline Review, H2 2020 - Product Thumbnail Image

Glycoprotein 41 (gp41) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Genital Herpes - Pipeline Review, H2 2020 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 123 Pages
  • Global
From
Bacterial Vaginosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Bacterial Vaginosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 75 Pages
  • Global
From
Toxoplasmosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Toxoplasmosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 48 Pages
  • Global
From
Anti-infectious Disease Drugs Companies in China - Product Thumbnail Image

Anti-infectious Disease Drugs Companies in China

  • Report
  • August 2024
  • 86 Pages
  • China
From
Anti-Infectious Disease Drugs Markets in China - Product Thumbnail Image

Anti-Infectious Disease Drugs Markets in China

  • Report
  • August 2024
  • 229 Pages
  • China
From
Infectious Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Infectious Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • May 2023
  • 116 Pages
  • Global
From
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 69 Pages
  • Global
From
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 34 Pages
  • Global
From
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 94 Pages
  • Global
From
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 60 Pages
  • Global
From
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 216 Pages
  • Global
From
Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 200 Pages
  • Global
From
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 44 Pages
  • Global
From
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 30 Pages
  • Global
From
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 44 Pages
  • Global
From
Prosthetic Joint Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Prosthetic Joint Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 54 Pages
  • Global
From
Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 39 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Loading Indicator

The Infectious Disease Drug market is a subset of the pharmaceutical industry that focuses on the development and production of drugs to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from bacterial and viral infections to fungal and parasitic diseases. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. They also work to ensure that their drugs are safe and effective. Some of the major players in the Infectious Disease Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. These companies are involved in the research, development, and production of drugs to treat a variety of infectious diseases. Show Less Read more